FDA Approves US WorldMeds' LUCEMYRA™ (lofexidine) After Priority Review for the Management of Opioid Withdrawal Symptoms
LUCEMYRA is the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptomsIn clinical trials, LUCEMYRA significantly reduced the severity of withdrawal symptoms compar...
Page (1) of 1 - 05/16/18||
(May 16, 2018)
This article is no longer available,but here are some related topics.
HTN - Health Technology Net
DMN Newswire Newsletter
All Rights Reserved